(Q45767325)

15 December 2017

title

Colorimetric assay system for screening antiviral compounds against hepatitis B virus (English)

1 reference

15 December 2017

1 reference

K Sudo

1

1 reference

15 December 2017

K Konno

series ordinal

2

1 reference

15 December 2017

S Shigeta

series ordinal

3

1 reference

15 December 2017

T Yokota

series ordinal

4

1 reference

15 December 2017

publication date

1 January 1996

1 reference

15 December 2017

Microbiology and Immunology

published in

1 reference

15 December 2017

volume

40

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

153-159

1 reference

15 December 2017

Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

Effect of oxetanocin G, a novel nucleoside analog, on DNA synthesis by hepatitis B virus virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

Two mammalian cell systems for propagation of the hepatitis B virus genome in extrachromosomal and chromosomally integrated states: production of the surface and e antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

An in vitro system for screening anti-hepatitis B virus drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB03319.X

10.1111/J.1348-0421.1996.TB03319.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017